Skip to content

Depression: all studies

Page 689 of 1,034: studies 6,881 to 6,890 of 10,336, newest first. Back to the depression overview

Research

Mindfulness-based Real-time fMRI Neurofeedback: A Randomized Controlled Trial to Optimize Dosing for Depressed Adolescents (Study Protocol)

September 23, 2023 Paul Alexander Bloom, David Pagliaccio, Jiahe Zhang et al. preprint

Adolescence is characterized by a heightened vulnerability for Major Depressive Disorder (MDD) onset, and currently, treatments are only effective for roughly half of adolescents with MDD. Accordingly, novel interventions are urgently needed. This study aims to establish mindfulness-based real-time fMRI neurofeedback (mbNF) as a non-invasive approach to downregulate the default mode network...

Effects of an App-Based Mindfulness Intervention during Pregnancy on the Infant’s Prenatal Androgen Exposure: A Randomized Controlled Pilot Trial

Journal of Clinical Medicine September 23, 2023 Eva-Maria Siegmann, Anna Eichler, Verena Nadine Buchholz et al. 2 citations

Prenatal androgen exposure modulates the development of the brain, with lasting effects on its function and behavior over the infant’s life span. Environmental factors during pregnancy, in particular maternal stress, have been shown to influence the androgen load of the unborn child. We here addressed the research gap on whether a mindfulness intervention or a pregnancy education administered...

Early onset Parkinson's disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report.

Journal of Medical Case Reports September 23, 2023 Tianyi Hui, Song Guo 2 citations

Current evidence linking the development of Parkinson's disease after the use of 3,4-methylenedioxymethamphetamine is mixed and limited, with only a few positive case reports demonstrating this. We examine this interesting case of a 49-year-old Chinese gentleman who used 3,4-methylenedioxymethamphetamine and subsequently developed early onset Parkinson's disease at age 38 years. He had a family...

DOI: 10.1186/s13256-023-04147-x (opens in new tab) Full text (opens in new tab) 3,4-Methylenedioxymethamphetamine MDMA Case report Parkinson’s disease

Periodic and aperiodic changes to cortical EEG in response to pharmacological manipulation.

bioRxiv September 22, 2023 Sofia V Salvatore, Peter M Lambert, Ann Benz et al. preprint

Cortical electroencephalograms (EEG) may help understanding of neuropsychiatric illness and new treatment mechanisms. The aperiodic component (1/ f ) of EEG power spectra is often treated as noise, but recent studies suggest that changes to the aperiodic exponent of power spectra may reflect changes in excitation/inhibition (E/I) balance, a concept linked to antidepressant effects, epilepsy,...

The Effectiveness of Providing Yoga Exercise Intervention with Islamic Spiritual Mindfulness Intervention on Anxiety Levels in Hypertension Patients at Ngoresan Health Center

International Journal of Public Health Excellence September 22, 2023 Tika Alvio Nita, Irma Mustikasari, Hermawati Hermawati

Background: The elderly are more at risk or tend to experience various diseases that often arise, namely hypertension. High blood pressure can cause the risk of stroke, heart failure and death. This death causes the elderly to become worried about their condition, so that the elderly experience psychological changes, namely anxiety that requires long treatment and excessive worry. Anxiety can...

IMPLICAÇÕES NEUROLÓGICAS DA MEDITAÇÃO DO TIPO TERAPIA COGNITIVA BASEADA EM MINDFULNESS EM PACIENTES COM TRANSTORNO DE ANSIEDADE OU TRANSTORNO DEPRESSIVO: UMA REVISÃO INTEGRATIVA

Arquivos de Ciências da Saúde da UNIPAR September 22, 2023 Bárbara Martins Machado, Lara Koury, Thiago Donizeth da Silva et al.

A Terapia Cognitiva Baseada em Mindfulness (MBCT, do inglês Mindfulness-Based Cognitive Therapy) é uma técnica baseada na combinação da Terapia Cognitiva-Comportamental e da meditação mindfulness, na busca pela melhoria de sintomas psiquiátricos. O presente trabalho tem como objetivo a busca por publicações que discutam as implicações neurológicas de pacientes diagnosticados com transtorno...

MDMA-Assisted Therapy for PTSD Shows Promise for Patients of Diverse Backgrounds

Psychiatric News September 22, 2023

Back to table of contents Previous article Next article Clinical & ResearchFull AccessMDMA-Assisted Therapy for PTSD Shows Promise for Patients of Diverse BackgroundsSearch for more papers by this authorPublished Online:22 Sep 2023https://doi.org/10.1176/appi.pn.2023.10.10.60AbstractMDMA appears to enhance the ability of individuals with PTSD to benefit from psychotherapy by softening their...

O PAPEL DOS ALUCINÓGENOS NO TRATAMENTO DE TRANSTORNOS MENTAIS E SUA RELEVÂNCIA NA PSIQUIATRIA: UMA REVISÃO INTEGRATIVA

Revista Ibero-Americana de Humanidades, Ciências e Educação September 22, 2023 Júlia Ruys Mattos Queiroz da Silva, Marcos Antônio Mendonça 2 citations

Este trabalho apresenta uma análise sobre a terapia psicodélica como uma possível abordagem para tratamentos psiquiátricos, visando a saúde mental, explorando suas raízes históricas, fundamentos neurobiológicos e resultados clínicos. A revisão da literatura revela que substâncias psicodélicas, como a psilocibina e o MDMA (ecstasy), demonstram um potencial terapêutico promissor para transtornos...

Expectancies for Subjective and Antidepressant Effects in Psilocybin Users

Journal of Humanistic Psychology September 22, 2023 Mitch Earleywine, Maha N. Mian, Joseph A. de Leo 5 citations

Expectancy effects for many psychoactive substances appear to play a role in consumption, problematic use, subjective responses to acute administration, and subsequent effects. Expectancies of psychedelics have received little attention in published research despite their reputation for creating dramatic changes in subjective state. Psilocybin-assisted treatment (PAT) improves depression, but...

Manic episode following psilocybin use in a man with bipolar II disorder: a case report

Frontiers in Psychiatry September 22, 2023 Haniya J Halim, Bradley G. Burk, Rachel E. Fargason et al. 13 citations

There has been an increase in research on the topic of psychedelic substances and their effects as treatment options in neuropsychiatric conditions. Psilocybin is a psychedelic drug that has recently garnered increased interest as an effective treatment modality for treatment-resistant depression, depression associated with terminal conditions, certain substance use disorders, and...